PubMed:11118434 / 669-797 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/11118434","sourcedb":"PubMed","sourceid":"11118434","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/11118434","text":"Expression of C2GnT1 is low or absent in around 50% of breast cancers, whereas expression of ST3Gal-I is consistently increased.","tracks":[{"project":"sentences","denotations":[{"id":"T5","span":{"begin":0,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T5","pred":"source","obj":"sentences"}]},{"project":"mondo_disease","denotations":[{"id":"T4","span":{"begin":55,"end":69},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"subj":"T4","pred":"source","obj":"mondo_disease"}]},{"project":"Anatomy-UBERON","denotations":[{"id":"T4","span":{"begin":55,"end":61},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"subj":"T4","pred":"source","obj":"Anatomy-UBERON"}]},{"project":"GlyCosmos15-HP","denotations":[{"id":"T4","span":{"begin":55,"end":69},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0003002"},{"subj":"T4","pred":"source","obj":"GlyCosmos15-HP"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"sentences","color":"#93eca0","default":true},{"id":"mondo_disease","color":"#ec939f"},{"id":"Anatomy-UBERON","color":"#93b9ec"},{"id":"GlyCosmos15-HP","color":"#d3ec93"}]}]}}